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Abstract 
Background: Alzheimer’s disease (AD) is one of the common neurodegenerative disorders among elderly. The 
purpose of this study was to determine the neuroprotective effect and mechanisms of action underlying the Terminalia 
chebula extracts and ellagic acid by using beta-amyloid25-35 (A25-35)-induced cell toxicity in an undifferentiated 
pheochromocytoma (PC12) cell line. 
Materials and Methods: The T. chebula extracts were prepared using the methanol, water, and 95% ethanol. 
Specifically, the ellagic acid was obtained in our laboratory. Assays including cell toxicity and changes in intracellular 
reactive oxygen species (ROS) and calcium level were evaluated to examine the neuroprotective effects and 
mechanisms of the T. chebula extracts and ellagic acid. 
Results: The methanolic and water extracts of T. chebula and ellagic acid exhibited the strongest neuroprotective 
activity against A25-35-induced PC12 cell damages at 0.5–5.0 g/ml. The ellagic acid also exhibited partial 
neuroprotective activity against H2O2-induced PC12 cell damages at 0.5–5.0 g/ml. The methanolic and water extracts 
of T. chebula and ellagic acid protected PC12 cells from A25-35-mediated cell damages and enhanced cell viability 
thorough two key mechanisms by: (1) inhibiting ROS production and (2) reducing calcium ion influx.  
Conclusion: The T. chebula represents a promising plant-source as medicine in the application for the treatment of AD. 
Further investigation focusing on the active component of T. chebula extracts e.g., ellagic acid is crucial to verify the 
neuroprotective efficacy and mechanisms in vivo. 
Keywords: Neuroprotective effect; Terminalia chebula; ellagic acid; beta-amyloid. 
 
Introduction 
 
Alzheimer’s disease (AD) is a common and severe neurodegenerative disorder in elderly people, inducing 
progressive memory loss and cognitive impairments. The neuropathology of AD is very complex and has yet to be 
completely understood. The extracellular beta-amyloid (A) deposition is a pathogenic mechanism in the AD brain.  
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Normally A is physiological product. Many studies have found that overproduction of Aβ results in a neurotoxic 
effect on nerve cells in vitro and in vivo. The A aggregates into amyloid fibrils, which cause the shrinkage of neurites 
and denaturing of neurons (Jack et al., 2010; Mayeux and Stern, 2012). Accumulation of A monomers into oligomers 
and lastly into plaques are both reported to mediate the toxicity of amyloid fibrils or plaques (Galimberti and Scarpini, 
2012). The rat pheochromocytoma cell line (PC12 cells) is a common cellular model used in the study of 
neuroprotective effects (Greene and Tischler, 1976). Therefore, the toxic effect of A in PC12 cells was used as a 
screening model in the study to identify potential neuroprotective components for AD. 
Terminalia chebula Retz. (Combretaceae) has been extensively reported to scavenge free radicals (Chang and Lin, 
2012), suppress cough (Ul Haq et al., 2013), treat arthritic disorders (Bag et al., 2013), elevate glucose uptake as 
PPAR/ dual agonists (Yang et al., 2013), protect the cells from ischemic damage (Gaire et al., 2013), and inhibit 
oxidative stress (Na et al., 2004). The radical scavenging from the water, methanol and 95% ethanol extracts of the T. 
chebula has been reported in our laboratory (Chang and Lin, 2012). Besides, the T. chebula cold aqueous extract has 
the potent anti-aging effect in vitro (Manosroi et al., 2010). The extract of T. chebula seeds protected neuronal cells 
from the damages in a transient cerebral ischemia (Park et al., 2011). 
Phytochemical study has shown that tannic acid, chebulagic acid, chebulinic acid, and corilagin are four major 
active ingredients of T. chebula (Park et al., 2011). Previous study in our laboratory has demonstrated that the methanol 
extract with the maximum total triterpenoid content and the water extract with the maximum total phenolic and tannin 
content of the T. chebula significantly protected PC12 cell against H2O2-induced cell death (Chang and Lin, 2012). In 
addition, the pure compound namely Tech-ME-A (ellagic acid) from T. chebula was purified in our laboratory (Hou et 
al., 2016). Here, the neuroprotective effects and mechanisms of action underlying the T. chebula extracts and ellagic 
acid were investigated by using A25-35-induced cell damages in PC12 cells. 
 
Material and Methods 
 
Methanol (Echo Chemical Corporation, LTD., Miaoli, Taiwan, R.O.C.) and 95% ethanol (Uni-Onward 
Corporation, Taipei, Taiwan, R.O.C.) were purchased as ACS grade reagents. Thirty-five percent H2O2 was purchased 
from Riedel-de Haën (Seelze, Germany). A25-35 was purchased from Kelowna International Scientific Inc. (Taipei, 
Taiwan, (R.O.C.). N-acetyl-Asp-Glu-Val-Asp-al (AC-DEVD-CHO) and 
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were originally obtained from 
Sigma-Aldrich Corporation, Shanghai, China. Curcumin was purchased from Acros Organics (ECHO Chemical 
Corporation, LTD., Taichung, Taiwan, R.O.C.). PC12 cell line was purchased from ATCC (Manassas, VA, USA). 
 
Extraction procedure 
 
The air-dried fruit of the T. chebula was purchased from Xin Long Pharmaceutical Limited Company (Taichung, 
Taiwan, R.O.C.). The fine powder was ground from the air-dried fruit using a stainless steel blender 
(Waring Commercial, Torrington, CT, U.S.A.). The dried powder (2 g) was each extracted three-times with methanol 
(20 ml), deionized water (20 ml) and 95% ethanol (20 ml), respectively. The mixtures were agitated for 15 min at room 
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temperature in an ultrasonic cleaner (model DC200H, Chemist Scientific Corporation, Taipei, Taiwan, R.O.C.) then 
filtered as described previously (Chang and Lin, 2012). All dried extracts were brown solids, and were stored at -20C 
prior to neuroprotective activity assays. 
 
Preparation of the A25-35 stock solution 
 
The A25-35 was prepared from the amyloid precursor protein, and it was pre-aggregated prior to use. Synthetic 
A25-35 was aggregated for 60 h at 4C and then for 8 h at 37C with mixing every 2 h before use as described 
previously. The stock solution (1 mM in water) was diluted to the desired concentration immediately before use and it 
was added to cell culture medium (Chang et al., 2013). 
 
Protective effects 
 
PC12 cell cultures were identical to those in our previous study (Chang and Lin, 2012). Various concentrations of 
test samples were 0, 0.5, 2.5 and 5.0 g/ml. The MTT cell viability assay as done in our previous study was used for 
the protective effect assay (Chang et al., 2013). 
 
Assay for intracellular reactive oxygen species (ROS) 
 
Various concentrations of test samples were 0, 0.5, 2.5 and 5.0 g/ml. The intracellular ROS was assayed as those 
in our previous study (Chang et al., 2013). We used a fluorescence spectrophotometer apparatus to measure 
fluorescence intensity at 485 nm (excitation wavelength) and 520 nm (emission wavelength). The final data were 
showed in relative fluorescence units. 
 
Assay for intracellular calcium 
 
Various concentrations of test samples were 0, 0.5, 2.5 and 5.0 g/ml. The intracellular calcium assay was 
completed as those in our previous study (Chang et al., 2013). Fluorescence intensity was also detected as above. 
 
Statistical analysis 
 
For evaluation of the sample’s protective effect, inhibition of the ROS production, and suppression of the calcium 
ion influx induced by H2O2 or A25-35 on PC12 cells were performed. All data are expressed as means  standard 
deviation (SD) based on data from three independent experiments using Microsoft Excel 2003. One-way ANOVA was 
used to analyze data for statistical significance, followed by a post hoc Tukey’s test using SPSS software (SPSS for 
Windows, Version 10). 
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Results and Discussion 
Protective effects 
We have reported that the neuroprotective effect of the T. chebula extracts may be attributed to their antioxidant 
properties. The methanol and water extracts exhibit the greater neuroprotective effects against H2O2-induced toxicity 
toward PC12 cells (Chang and Lin, 2012). According to our previous study, the induction of cell damages using 40 M 
H2O2 for 12 h and 0.01 M A25-35 for 24 h were used in the experiments (Chang et al., 2013). Cell viability decreases 
to 49.7  7.4% when PC12 cells exposed to H2O2 (40 M) for 12 h. We found that the ellagic acid inhibited 
H2O2-induced toxicity at 0.5–5.0 g/ml (cell viability = 65.3–71.1%). To further study the neuroprotective effects of 
the T. chebula extracts and ellagic acid, we used A25-35-induced PC12 cell death to evaluate the neuroprotective effects 
by these samples. Table 1 shows the protective effects. Cell viability decreases to 48.6  5.1% when exposed to A25-35 
(0.01 M) for 24 h. Using AC-DEVD-CHO and curcumin as two positive controls, the extracts and ellagic acid all 
concentration-dependently inhibited A25-35-induced toxicity at concentrations ranging from 0.5–5.0 (μg/ml) up to 24 h 
with potency in the following as descending order: methanol extract > water extract > ellagic acid > curcumin > 
AC-DEVD-CHO > 95% ethanol extract. No significant cytotoxicity of the extracts and ellagic acid could be observed 
between 0.5–5.0 μg/ml up to 24 h (data not shown). The methanol extract, water extract, ellagic acid and curcumin 
significantly inhibited A25-35-induced toxicity at dose rages of 0.5–5.0 g/ml. It is notice that ellagic acid could 
significantly reduce A42-induced neurotoxicity as that been reported in SH-SY5Y cell model (Feng et al., 2009). 
Ellagic acid exhibited neuroprotective effects against oxidative damage in diabetic rats (Uzar et al., 2012). The 
95% ethanol extract partially inhibited A25-35-induced toxicity at dose rages of 2.5 and 5.0 g/ml. AC-DEVD-CHO 
partially inhibited A25-35-induced toxicity at a dose of 2.5 g/ml, but it clearly inhibited A25-35-induced toxicity at a 
dose of 5.0 g/ml. The methanolic extract displayed the greatest neuroprotective effect among the extracts and ellagic 
acid. Based on these results, and our previous findings (Chang and Lin, 2012), we proposed that the potent 
neuroprotective effect of the methanol-extract of T. chebula is largely completed by its antioxidant activities achieved 
by its total triterpenoid content. These findings demonstrate for the first time that the methanol and water extracts of 
T. chebula, and ellagic acid can significantly ameliorate the H2O2 and A25-35-induced PC12 cell damages. 
Table 1: Protective effects of the samples and positive control on A25-35-induced PC12 cell damages. 
Sample Concentration (μg/ml) Cell viability (%) 
Control 0 100.0  3.3 
A25-35 0.01 μM 48.6  5.1# 
Methanol extract 0.5 70.4  6.8 
 2.5 114.5  5.5* 
 5.0 163.9  10.8** 
Water extract 0.5 92.4  8.8 
 2.5 106.9  5.7* 
 5.0 122.3  3.0** 
95% Ethanol extract 0.5 40.9  5.7 
 2.5 62.5  6.2 
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 5.0 71.2  3.5 
Ellagic acid 0.5 91.2  7.8 
 2.5 98.4  6.1* 
 5.0 105.1  8.8* 
AC-DEVD-CHO 0.5 45.5  7.9 
 2.5 64.0  5.2 
 5.0 94.6  8.6 
Curcumin 0.5 91.6  3.2 
 2.5 93.5  6.1 
 5.0 102.0  5.4* 
These data are showed as mean  SD for 3 replicates. #P  0.01 versus the control group without the addition of the 
sample and A25-35 solutions, *P  0.05; **P  0.01 versus the 0.01 M A25-35-treated group without the addition of 
the sample solution. 
 
Assay for intracellular ROS 
 
This assay demonstrates that H2O2 and A25-35 induced the production of ROS. After treatment with the samples, 
the H2O2 and A25-35-induced ROS were reduced. The various decreases in PC12 cell H2O2-induced ROS productions 
for the samples, AC-DEVD-CHO and curcumin, in decreasing order of activity, were 95% ethanol extract > 
AC-DEVD-CHO > methanol extract > water extract > ellagic acid > curcumin. The various reductions in PC12 cell 
ROS-production activities induced by A25-35 for the samples, AC-DEVD-CHO and curcumin were in decreasing order 
of ellagic acid > curcumin > AC-DEVD-CHO > water extract > 95% ethanol extract > methanol extract. However, 
these results were not dose-dependent responses except for 95% ethanol extract and AC-DEVD-CHO under the 40 M 
H2O2 condition and AC-DEVD-CHO under the 0.01 M A25-35 condition (Table 2). The 95% ethanol extract’s high 
activity in reduction in H2O2-induced ROS production has a low dependence on its neuroprotective effect against H2O2 
toxicity to PC12 cells (Chang and Lin, 2012). The ellagic acid’s high activity in reduction in A25-35-induced ROS 
production is a high dependence on its neuroprotective effect against A25-35 toxicity to PC12 cells, but it expresses the 
lowest decrease in H2O2-induced ROS production. In addition, H2O2-induced ROS production was enhanced by 43.2% 
after the addition of 2.5 g/ml ellagic acid to the culture medium. The H2O2-induced ROS production was enhanced by 
121.1% and 45.2% after the addition of 2.5 and 5.0 g/ml curcumin to the culture medium. Methanol extract exhibits the 
good neuroprotective effect against A25-35 toxicity to PC12 cells, but it expresses the lowest decrease in 
A25-35-induced ROS production. 
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Table 2: Protective effects of the samples and positive control on the intracellular ROS production induced by H2O2 or 
A25-35 in PC12 cells. 
Sample 
Concentration 
(μg/ml) 
DCF fluorescence intensity 
(% of control) by H2O2 
DCF fluorescence intensity 
(% of control) by A25-35 
Control 0 100.0  4.2 100.0  5.5 
H2O2 40 M  192.5  4.4#  
A25-35 0.01 M   199.8  6.3# 
Methanol extract 0.5     96.1  11.0**  146.2  8.5* 
 2.5   127.4  10.7*  128.8  8.2* 
 5.0     92.4  12.1**   135.3  12.3* 
Water extract 0.5    98.7  3.9**   114.2  11.6* 
 2.5  120.4  5.1*    98.0  7.2** 
 5.0  140.2  5.3*  120.8  9.6* 
95% Ethanol extract 0.5    87.9  3.4**     97.2  11.4** 
 2.5    85.7  4.2**  141.1  4.3* 
 5.0    81.6  4.7**  134.5  9.2* 
Ellagic acid 0.5 157.7  4.9    35.8  1.5** 
 2.5 235.7  6.2    52.4  2.1** 
 5.0 196.9  3.4    48.2  3.3** 
AC-DEVD-CHO 0.5    107.8  11.0**  109.0  5.4* 
 2.5     92.0  12.4**   104.7  10.2* 
 5.0    62.9  5.6**    62.9  5.6** 
Curcumin 0.5   110.7  5.2**    43.2  2.3** 
 2.5    313.6  11.9**    46.8  2.1** 
 5.0  237.7  10.9  110.9  5.9* 
These data are expressed as mean  SD for 3 replicates. #P  0.001 versus the control group without the addition of the 
sample and H2O2 or A25-35 solutions, *P  0.01; **P  0.001 versus the 40 M H2O2 or 0.01 M A25-35-treated 
groups without the addition of the sample solution. 
 
Assay for intracellular calcium 
 
The intracellular calcium by 40 M H2O2 and 0.01 M A25-35 was significantly improved by 132.2 % and 115.2 
%, respectively. Table 3 shows the effects on intracellular calcium, of preincubation or coincubation with samples, and 
40 M H2O2 or 0.01 M A25-35. The different decreases in PC12 cell calcium-production activities in response to H2O2 
for the samples, AC-DEVD-CHO and curcumin in decreasing order of activity were curcumin > 95% ethanol extract > 
water extract > ellagic acid > methanol extract > AC-DEVD-CHO. The different decreases in PC12 cell 
calcium-production activities, induced by A25-35, for the samples, AC-DEVD-CHO and curcumin in decreasing order of 
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activity were ellagic acid > curcumin > water extract > methanol extract > 95% ethanol extract > AC-DEVD-CHO. The 
95% ethanol extract’s high activity in reduction in H2O2-induced calcium production has a low dependence on its 
neuroprotective effect against H2O2 toxicity to PC12 cells (Chang and Lin, 2012). It expresses the lowest decrease in 
A25-35-induced calcium production, but it is a medium dependence on its neuroprotective effect against A25-35 toxicity 
to PC12 cells. The ellagic acid’s high activity in reduction in A25-35-induced calcium production has a high dependence 
on its neuroprotective effect against A25-35 toxicity to PC12 cells. Methanol extract exhibits the good neuroprotective 
effect against H2O2-induced toxicity to PC12 cells (Chang and Lin, 2012), but it expresses the lowest decrease in 
H2O2-induced calcium production. Table 3 shows that water extract can regulate calcium production, and it is able to 
decrease H2O2 or A25-35 toxicity. 
 
Table 3: Protective effects of the samples and positive control on the intracellular calcium elevation as induced by 
H2O2 or A25-35 in PC12 cells. 
Sample 
Concentration 
(μg/ml) 
Intracellular calcium 
(% of control) by H2O2 
Intracellular calcium 
(% of control) by A25-35 
Control 0 100.0  5.1 100.0  6.3 
H2O2 40 M  232.2  8.8#  
A25-35 0.01 M   215.2  7.8# 
Methanol extract 0.5  188.7  11.7   113.8  11.6* 
 2.5  140.6  3.5*   104.4  5.3** 
 5.0  124.4  4.7*   107.9  4.3** 
Water extract 0.5    101.4  10.3**    90.5  6.8** 
 2.5    96.1  8.7**  117.1  2.3* 
 5.0   137.8  11.7*   100.5  6.5** 
95% Ethanol extract 0.5    86.9  7.4**  121.6  3.9* 
 2.5   103.2  9.7**  115.2  3.5* 
 5.0    97.9  5.3**  122.7  5.8* 
Ellagic acid 0.5  125.4  9.7*  111.4  5.6* 
 2.5  142.6  3.4*    64.0  7.4** 
 5.0  147.2  5.2*    56.5  1.4** 
AC-DEVD-CHO 0.5   146.1  12.8*   109.0  7.4** 
 2.5  147.1  4.2*  144.0  6.1* 
 5.0  151.9  8.6*   122.3  10.3* 
Curcumin 0.5    82.6  9.2**    82.5  5.6** 
 2.5    54.9  7.5**    87.5  9.8** 
 5.0    52.5  4.9**  140.6  3.2* 
These data are expressed as mean  SD for 3 replicates. #P  0.001 versus the control group without the addition of the 
sample and H2O2 or A25-35 solutions, *P  0.01; **P  0.001 versus the 40 M H2O2 or 0.01 M A25-35-treated 
Shen et al., Afr J Tradit Complement Altern Med., (2017) 14 (4): 22-30 
https://doi.org/10.21010/ajtcam.v14i4.3 
 
29 
 
groups without the addition of the sample solution. 
 
Conclusion 
 
We have demonstrated the ability of the T. chebula extracts and ellagic acid to prevent H2O2 or A25-35-induced 
PC12 cell damages. Our results reveal that the methanolic and water extracts exhibited favorable neuroprotective 
activities against H2O2 and A25-35-induced toxicity towards PC12 cells, and are potential candidates for treating H2O2 
and A25-35-induced neurodegenerative diseases. We also show that ellagic acid ameliorated H2O2 and A25-35-induced 
PC12 cell damages. Induction of ROS in PC12 cells by A25-35 maybe associated with oxidative stress-mediated 
cytotoxicity. Ellagic acid has been shown to suppress A25-35-induced ROS production in PC12 cells. Further, we have 
demonstrated that H2O2 and A25-35 decreased the intracellular calcium production in PC12 cells was modulated by 
exposure to ellagic acid. 
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